Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
This study is a global, randomized, double-blind, placebo-controlled clinical trial (n=11000) aimed at evaluating the effectiveness and safety of Zilebesiran (300mg, subcutaneous injection, once every 6 months) combined with standard treatment (OC) compared to placebo combined with SOC in reducing the incidence of major cardiovascular adverse events (MACE) in hypertensive adult patients with diagnosed cardiovascular disease or poor blood pressure control at high risk of cardiovascular disease
Schedule your first consultation at New Concept Healthcare | Functional Medicine Gaffney, home of the $1 Consultation and Highest and Most Reviewed Functional Medicine Clinic in South Carolina.
Its also being explored for its potential role in managing conditions like polycystic ovary syndrome (PCOS) and congestive heart failure
High-throughput screening using dengue virus reporter genomes
[PMID: 9102927] PubMed record related to this compound for laboratory literature review
50 , e330e335 (2021)
US$ 22.24
US$ 27.15
US$ 29.84
US$ 29.10
US$ 18849.50
Sold : Login>>
